Dr. Abert Thomas Indresano is a San Francisco, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2155 Webster St, Suite 522f, San Francisco. Patients can reach him at 415-929-6649.
Dr. Abert Thomas Indresano deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Abert Thomas Indresano speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Abert Thomas Indresano
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
2155 Webster St, Suite 522f, San Francisco, California, 94115-2333
Phone:
415-929-6649
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
8426111972
Enrollment ID:
I20090110000015
NPI Number:
1629108550
NPI Enumeration Date:
07 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2155 Webster St, Suite 522f San Francisco, California
Zip:
94115-2333
Phone Number:
510-864-4105
Patients can reach Dr. Abert Thomas Indresano at 2155 Webster St, Suite 522f, San Francisco, California or can call to book an appointment on 415-929-6649. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.